I think there is a risk of waiting too long to release retatrutide, given the supersonic development of other potentially more effective agents. For example, Bioglutide is a quadruple-receptor agonist and is in phase 2 trials as an oral formulation and as a combined formulation with other GLPs.
Supposedly, Bioglutide works better, faster, with fewer side effects and causes minimal bone/muscle loss. Best of all, it makes you instantly well-hung, that's right, instantly well-hung (ok, I might have dreamt that last part
😎).